申请人:Chen Ning
公开号:US20080227779A1
公开(公告)日:2008-09-18
The present invention comprises a new class of compounds capable of modulating the c-kit protein kinase and, accordingly, useful for treatment of c-kit mediated diseases including, without limitation, autoimmune disease, allergies, mastcytosis, mast cell related tumors and various fibrotic diseases. The compounds have a general Formula I
wherein R
1-5
, X, Y and Z are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of c-kit mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.
本发明包括一类新的化合物,能够调节c-kit蛋白激酶,并因此用于治疗c-kit介导的疾病,包括但不限于自身免疫性疾病、过敏、肥大细胞增生症、肥大细胞相关肿瘤和各种纤维化疾病。这些化合物具有一般的I式,其中R1-5,X,Y和Z在此定义。本发明还包括制药组合物,治疗c-kit介导的疾病的方法,以及制备本发明化合物的中间体和方法。